The 12th Annual

Canadian Hematology Conference 2022

Report & Videos on-Demand


05 Oct 2022

The 12th annual Canadian Hematology Conference meeting was streamed on Sept. 30th – Oct. 1st 2022. As a follow-up to the meeting, all video components and slide decks are featured in the CHC 2022 virtual report for easy access.

Each section includes a presentation video, Q&A video (if applicable), and presenter slides.

Aggressive B-Cell Lymphoma

Frontline Therapy [ + Q&A ]

Dr. Laurie Sehn, BCCA, Vancouver

Click to Access
Second Line (And Beyond) [ + Q&A ]

Dr. Michael Crump, PMCC, Toronto

Click to Access

Indolent (Follicular and Mantle Cell) Lymphoma

Managing patients with Relapsed/Refractory Follicular Lymphoma [ + Q&A ]

Dr. Gilles Salles, Memorial Sloan Kettering, NY

Click to Access
Recent Advances in the Management of Mantle Cell Lymphoma [ + Q&A ]

Dr. Diego Villa, BCCA, Vancouver

Click to Access
Advances in BiTE Therapy for Lymphoma [ + Q&A ]

Rob Laister PhD, PMCC, Toronto

Click to Access

Hodgkin Lymphoma

Approaches in Frontline Advanced Hodgkin Lymphoma [ + Q&A ]

Dr. Alison Moskowitz, Memorial Sloan Kettering, New York

Click to Access
Dr. John Kuruvilla
Primary Treatment of Localized Hodgkin Lymphoma

Dr. John Kuruvilla, PMCC, Toronto

Click to Access
Hodgkin Lymphoma: Future Directions in Treatment

Dr. Stephen Ansell, Mayo Clinic, Rochester, MN

Click to Access

Plasma Cell Dyscrasias

Newly Diagnosed Multiple Myeloma [ + Q&A ]

Dr. Keith Stewart, PMCC, Toronto

Click to Access
Multiple Myeloma – Relapsed Disease [ + Q&A ]

Dr. Rafael Fonseca, Mayo Clinic, Arizona

Click to Access
New Agents in Multiple Myeloma

Dr. Paola Neri, Arnie Charbonneau Cancer Institute, Calgary

Click to Access

Myeloid Leukemia

The Evolving Landscape of Frontline Therapy
  • a. intensive induction
  • b. non-intensive induction

Dr. Guillaume Richard-Carpentier, PMCC, Toronto

Click to Access

Chronic Lymphocytic Leukemia

Frontline CLL Treatment [ + Q&A ]

Dr. Stephan Stilgenbauer, Ulm University, Germany

Click to Access
Management of CLL in the Relapsed Setting: a Canadian Perspective [ + Q&A ]

Dr. Versha Banerji, CancerCare Manitoba, Winnipeg

Click to Access